|
XDNA
|
Kelly CRISPR & Gene Editing Technology ETF
|
US
|
NASDAQ
|
|
GSS
|
Genetic Signatures Ltd
|
AU
|
ASX
|
|
PYC
|
Phylogica Limited
|
AU
|
ASX
|
|
ABCZF
|
Abcam plc
|
US
|
OTC
|
|
AGTT
|
Angstrom Technologies Inc
|
US
|
OTC
|
|
BMGP
|
Biomagnetics Diagnos
|
US
|
OTC
|
|
DNAG
|
Dnaprint Genomics
|
US
|
OTC
|
|
GTHR
|
Genethera Inc
|
US
|
OTC
|
|
LXXGF
|
Lexagene Holdings
|
US
|
OTC
|
|
PHGUF
|
Pharming Grp Nv Leid
|
US
|
OTC
|
|
SLNCF
|
Silence Therapeutics
|
US
|
OTC
|
|
VBIZF
|
Viva Biotech Holdings
|
US
|
OTC
|
|
VILGF
|
Yourgene Health Plc
|
US
|
OTC
|
|
ARKG
|
BMO ARK Genomic Revolution Fund
|
CA
|
TSX
|
|
PSYB
|
Psybio Therapeutics Corp
|
CA
|
TSXV
|
|
GENF
|
Genflow Biosciences plc
|
UK
|
LSE
|
|
IDHC
|
Integrated Diagnostics H
|
UK
|
LSE
|
|
MXCT
|
Maxcyte Inc
|
UK
|
LSE
|
|
NCYT
|
Novacyt S.A.
|
UK
|
LSE
|
|
ROQ
|
Roquefort Investments plc
|
UK
|
LSE
|